Bausch Health, Canada Inc.

Bausch Health, Canada Inc., an international for-profit pharmaceutical manufacturer, supplies pyridostigmine bromide tablets to the federal government as a subcontractor, exclusively through Canadian Commercial Corporation as the prime contractor. The vendor operates solely in a subcontract capacity and holds no prime contract awards or federal vehicles.

Bausch Health's federal footprint is narrow and specialized. All three sub awards in the source data involve the same product — pyridostigmine bromide tablets — procured by the Defense Logistics Agency Troop Support Medical (DLA-TRSM), the sole customer agency across the portfolio. Task orders flow through a single parent vehicle, Indefinite Delivery Contract SPE2DP21D0002, managed by Canadian Commercial Corporation. The three recent sub awards span April 2025, July 2025, and September 2026, indicating ongoing demand for the product but a sparse award cadence — two awards in 2025 and one in 2026.

The vendor's federal activity is confined to pharmaceutical preparation manufacturing (NAICS primary). As a Canadian-domiciled entity supplying to DLA-TRSM through Canadian Commercial Corporation, Bausch Health likely qualifies under Foreign Military Sales (FMS) or similar international procurement frameworks that channel purchases through designated primes. The absence of prime awards and the exclusive use of Canadian Commercial Corporation as an intermediary suggest the vendor functions as a supply-chain input rather than a direct federal contractor — a pharmaceutical ingredient or finished-good supplier whose relationship with the U.S. federal government is transactional and mediated through government-to-government or government-designated-prime-to-vendor relationships. The limited award history (three sub awards over eighteen months) and absence of growth trajectory make competitive or partnership analysis difficult; the vendor appears as a specialty pharmaceutical supplier to DLA medical procurement, not a broad federal services or IT capability provider.